3-179875375-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016559.3(PEX5L):c.608C>A(p.Thr203Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016559.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX5L | NM_016559.3 | c.608C>A | p.Thr203Asn | missense_variant | 6/15 | ENST00000467460.6 | NP_057643.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX5L | ENST00000467460.6 | c.608C>A | p.Thr203Asn | missense_variant | 6/15 | 1 | NM_016559.3 | ENSP00000419975.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152130Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000163 AC: 41AN: 251466Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135910
GnomAD4 exome AF: 0.0000561 AC: 82AN: 1461576Hom.: 0 Cov.: 32 AF XY: 0.0000591 AC XY: 43AN XY: 727108
GnomAD4 genome AF: 0.000197 AC: 30AN: 152130Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.608C>A (p.T203N) alteration is located in exon 6 (coding exon 6) of the PEX5L gene. This alteration results from a C to A substitution at nucleotide position 608, causing the threonine (T) at amino acid position 203 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at